Skip to main content
Top
Published in: Radiation Oncology 1/2020

Open Access 01-12-2020 | Commentary

PITChing (professional organisations, innovative trial designs and collaborative approach) for evidence generation for proton therapy

Authors: Srinivas Chilukuri, Pankaj Kumar Panda, Rakesh Jalali

Published in: Radiation Oncology | Issue 1/2020

Login to get access

Abstract

Developments in the field of proton beam therapy (PBT) have recently crossed the tipping point wherein the modality is now more versatile than ever before, with possibilities and likely indications expanding rapidly.
However the pace of evidence generation lags behind the developments in the field.
Generating quality evidence has its own set of challenges owing to complexities of conducting randomized controlled trials, which are the hallmark of level 1 evidence generation.
Here we discuss various challenges to clinical evidence generation in PBT and have suggested certain solutions including collaborative approaches and alternative study designs to mitigate these challenges.
Literature
2.
go back to reference Bekelman JE, Denicoff A, Buchsbaum J. Randomized trials of proton therapy: why they are at risk, proposed solutions, and implications for evaluating advanced technologies to diagnose and treat Cancer. J Clin Oncol. 2018;36(24):2461–4.CrossRef Bekelman JE, Denicoff A, Buchsbaum J. Randomized trials of proton therapy: why they are at risk, proposed solutions, and implications for evaluating advanced technologies to diagnose and treat Cancer. J Clin Oncol. 2018;36(24):2461–4.CrossRef
3.
go back to reference Panda PK, Jalali R. Global Cancer clinical trials-cooperation between investigators in high-income countries and low- and middle-income countries. JAMA Oncol. 2018;4(6):765–6.CrossRef Panda PK, Jalali R. Global Cancer clinical trials-cooperation between investigators in high-income countries and low- and middle-income countries. JAMA Oncol. 2018;4(6):765–6.CrossRef
4.
go back to reference Liao Z, Lee JJ, Komaki R, et al. Bayesian adaptive randomization trial of passive scattering proton therapy and intensity-modulated photon radiotherapy for locally advanced non-small-cell lung Cancer. J Clin Oncol. 2018 Jun 20;36(18):1813–22.CrossRef Liao Z, Lee JJ, Komaki R, et al. Bayesian adaptive randomization trial of passive scattering proton therapy and intensity-modulated photon radiotherapy for locally advanced non-small-cell lung Cancer. J Clin Oncol. 2018 Jun 20;36(18):1813–22.CrossRef
6.
go back to reference Mittra I, Mishra GA, Singh S, et al. A cluster randomized, controlled trial of breast and cervix cancer screening in Mumbai, India: methodology and interim results after three rounds of screening. Int J Cancer. 2010;126(4):976–84.PubMed Mittra I, Mishra GA, Singh S, et al. A cluster randomized, controlled trial of breast and cervix cancer screening in Mumbai, India: methodology and interim results after three rounds of screening. Int J Cancer. 2010;126(4):976–84.PubMed
Metadata
Title
PITChing (professional organisations, innovative trial designs and collaborative approach) for evidence generation for proton therapy
Authors
Srinivas Chilukuri
Pankaj Kumar Panda
Rakesh Jalali
Publication date
01-12-2020
Publisher
BioMed Central
Published in
Radiation Oncology / Issue 1/2020
Electronic ISSN: 1748-717X
DOI
https://doi.org/10.1186/s13014-020-01538-y

Other articles of this Issue 1/2020

Radiation Oncology 1/2020 Go to the issue